FDA Has Lots of New Guidance Planned for 2013, including Track and Trace and Compounding

Draft Guidances For 2013 Will Grapple With Biosimilars, Track and Trace, Compounding

By Brenda Sandburg / Email the Author / Feb. 11, 2013 
Regulatory Update / Word Count: 928 / Article # 00130211012 / Posted: February 11 2013 12:00 AM

---

Executive Summary

FDA’s Center for Drug Evaluation and Research plans to publish more than 50 new and revised draft guidances this calendar year.

To buy this report, click here